Clinical Pharmacology and Toxicology

Welcome Message

Wе arе еxcitеd to invitе thе еntirе contributor from all ovеr thе world to attеnd thе “5th Intеrnational Confеrеncе on Clinical Pharmacology and Toxicology” during Octobеr 02-03, 2023 in Frankfurt, Gеrmany. Wе trust that wе havе chosеn a placе that confirms thе confеrеncе.

This confеrеncе covеrs thе sеssions of pharmacology and taxonomy, pharmacodynamics, drug dеlivеry, drug safеty, bioavailability, pharmacokinеtics, nanotеchnology. Our aim is to highlights advancеmеnts in pharmacology and toxicological studiеs.

Join us for whеrе, toxicologists, pharmacokinеtics, sciеntists, Invеstigators, biotеchnologists, clinicians, associations, and junior rеsеarch fеllows sharе thе most rеcеnt findings, advancеmеnts in pharmacology, and toxicology.

This will offеr a hugе platform for studеnts and young rеsеarchеrs to еxplorе thеir work.

Wе hеartily wеlcomе you all to participatе in this honorablе еvеnt.

On bеhalf of thе Organizing committее

Clinical Pharmacology 2023

About Conference

Clinical Pharmacology 2023 focuses on the importance to understand drugs and how they can affect the human physiology. It is easy with better understanding of Pharmacology one can know the right dosage and dosage forms of drugs. Most research in pharmacology deals with identifying and responding to drug interactions and its side effects along with its mechanism of action, its therapeutic index and thereby treat accordingly. More intensive study with the interaction between drug and its therapeutic effect helps to identify the properties of ideal drugs. The main two branches of Pharmacology is Pharmacodynamics and Pharmacokinetics. Pharmacokinetics is defined as the movement of drugs through the body where as Pharmacodynamics is defined as the body's biological response to drugs.

Why to attend?

Join your peers around the world focused on learning about Pharmacology and related advances, which is your single best opportunity to reach the largest assemblage of participants from the various Pharmacology community, conduct demonstrations, distribute information, meet with current and potential professionals, make a splash with a new research works, and receive name recognition at this 2-day event. World-renowned speakers, the most recent research, advances, and the newest updates in Pharmacology are hallmarks of this conference.

Target Audience:

Students, Scientists, Researchers, Faculty of Pharmaceutical Universities Medical Colleges, Researchers from Pharmaceutical Companies, Pharmacy Associations and Societies

Business Entrepreneurs, Training Institutes, Software developing companies

Manufacturing Medical Devices Companies, CRO and Data Management Companies.

Young Scientist Benefits

• Our conferences provide best Platform for your research through oral presentations.
• Share the ideas with both eminent researchers and mentors.
• Young Scientist Award reorganization certificate and memento to the winners
• Young Scientists will get appropriate and timely information by this Forum.
• Platform for collaboration among young researchers for better development
• Award should motivate participants to strive to realize their full potential which could in turn be beneficial to the field as whole.

Sessions/ Tracks

• Behavior toxicology

• Biochemical Pharmacology

• Drug Safety

• Genotoxicity

• Bio-availability

• Bio-equivalence

• Biologic drugs

• Clinical and medical pharmacology

• Drug discovery and Drug development

• Environmental Toxicology

• Microbial Toxicology

• Molecular Pharmacology

• Nanomedicine and Nanotechnology

• Pharmaceutical biotechnology

• Pharmacodynamics

• Pharmacogenomics

• Pharmacokinetics

• Pharmacology and Toxicology

• Pharmacovigilance

• Route of administration

Benefits of Participation

Clinical Pharmacology 2023, provides the participants with different modes or ways to participate under either Academic / Student / Business Category

1. Keynote speaker: 45-50 minutes
2. Speaker (oral presentation): 25-30 minutes (only one person can present)
3. Speaker (workshop): 45-50 minutes (more than 1 can present)
4. Speaker (special session): 45-50 minutes (more than 1 can present)
5. Speaker (symposium): more than 45 minutes (more than 1 can present)
6. Delegate (only registration): will have access to all the sessions with all the benefits of registration
7. Poster presenter:  can present a poster and enjoy the benefits of delegate
8. Remote attendance:  can participate via video presentation or e-poster presentation
9. Exhibitor: can exhibit his/her company’s products by booking exhibitor booths of different sizes
10. Media partner
11. Sponsor
12. Collaborator

Advantages of Participating at our Conference

• The Speaker and Abstract pages that Google creates on your profile under your name would give you global visibility.
• Our Library of Abstracts receives more than 30,000 visits per month and 50 thousand views, which brings scholars and speakers to our Conference.
• Meet and exchange ideas with thousands of thought leaders in obesity and nutritional health.
• Each conference attendee would have a different motivation for engaging in one-on-one discussions with distinguished speakers and recognized keynote speakers.
• At our Keynote presentations, you'll have the exceptional chance to hear what the world's foremost authorities on obesity are discovering.

Benefits of Participation for Speaker

• Admiration for researchers' profile on a global scale.
• Obtain points for your professional development.
• Discover the most recent cutting-edge analysis.
• Become lifelong friends through social and networking activities.
• An opportunity to promote one page through the distribution of abstract books and flyers, which eventually receives 1 million views and greatly enhances your research profile.
• Learn about new topics and studies that are unrelated to your primary subject of obesity and nutritional health by making a transition outside of your field of interest.
• We've combined exceptional networking, education, and fun into one bundle.

Benefits of Participation for Delegate

• Increased knowledge and understanding for professional development.
• Attending webinars helps participants feel refreshed and energized.
• Your participation in our conference will support the development of a new approach and philosophy that can be used to improve business or industry results.
• Opportunities for OBESITY SUMMIT scholars and practitioners to connect and share new perspectives online and at conferences.

Benefit of Participation for Sponsor

• The likelihood of new businesses would rise with exposure to the global marketplace.
• A chance to showcase your business's most cutting-edge innovations, fresh products, or services to a large international audience.
• Lead generation will help our webinar participants do more business.
• To draw energy from others who have a similar purpose and objective, it's always helpful to have a network of co-workers and associates. Building a successful firm takes a lot of time, effort, and drive.
• Webinars on obesity offer chances for greater thought and reflection, which might help you advance your business.
• Comparing the major organization's plans and advancing them.
• Get answers to your company's queries and difficulties at our conference from reliable people.

Benefit of Association for Collaborators

• No other website has this many visits, making Obesity the finest platform for bringing attention to society.
• Establishing enduring peer ties.
• Your organization's logo, branding and marketing materials, promotional content, and the webinar banner will all work together to add 40% more subscribers and members to your list.
• Your association will be greatly impacted by the visibility of our event to your company's placement in the Global Business forum.
• Your representatives can interact with important delegates to update their knowledge and comprehension of your organization and services.
• Information will be incorporated into obesity advertising materials such posters, brochures, pamphlets, and services that will be distributed to hospitals, universities, the general public, and researchers.

Market Analysis

The pharmaceutical industry comprises of companies that are engaged in research, development, manufacture and distribution drugs for human or veterinary use. The primary function of the research-based pharmaceutical corporations is to create value by discovering and producing effective medicines, vaccines and services that improve patients’ well-being, and can be sold in markets at a profit. As well as increasing shareholder value, this contributes significantly to the quality and protection of life and helps make the world a better place. In the past 60 years, innovation and technology have driven huge improvements in global health.

Every clinical trial in Austria has to be approved by the Federal Office for Safety in Healthcare and needs a positive opinion of the ethics committee. Details on terminological definitions and on the requirements and implementation of clinical trials are set out in the Medicinal Products Act in § 2a and § 28 to § 48. The objective is to prove the effectiveness and tolerability of these forms of treatment and to improve the medical care of future patients. In principle, a distinction is made between clinical trials (intervention studies) and non-interventional studies.

Market Analysis of Global Pharmaceutical Industries

The global $1.12 trillion market in 2022, will rise at a faster clip during 2016-2020, then slow down a bit as major patent expiration take hold. It is expected that the global market declined by 1.0% in 2015, but will grow by 4.8% this year. Prescription sales excluding generics will rise 4.4% this year, and expected to reach $1.006 trillion in 2022. Generics sales will increase from $73 billion in 2015 to $115 billion in 2022, and constitute 10.2% of prescription sales at that point only 0.3 percentage points more than it is now.

The global market for drug discovery technologies and products was worth $38.4 billion in 2011. This figure is projected to reach $41.4 billion in 2012 and $79 billion in 2017, a five-year compound annual growth rate (CAGR) of 13.8%. There is a need to impede serious adverse effects caused by the drugs by enhancing drug targeting through research in pharmacology.

The global revenue for single use technology reached $1.4 billion and $1.7 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.7% to nearly $3.0 billion for the period 2014-2019.

The fast-growing division of the pharmaceutical market includes generics and biologics. Biologics now account for over a third of all new drugs in clinical trials or awaiting FDA approval.15 U.S generic drug sales reached an estimated $70 billion, representing a quarter of the global market, due to a large number of drugs going off-patent and healthcare reforms favoring generics. Although generics make up only 22 percent of total prescription sales, its share of filled prescriptions has risen from 19 percent in 1984 to 88 percent in 2015. The research-based pharmaceutical industry is estimated to have spent nearly USD 149.8 billion globally on pharmaceutical R&D in 2015-16. Among all the industrial sectors, the research-based pharmaceutical industry has consistently invested the most in research and development, even in times of economic turmoil and monetary crisis.

According to the QuintilesIMS Institute predicts that the pharmaceutical market by 2021 will reach nearly USD 1,485 billion, by an increase of USD 350-380 billion from the USD 1,105 billion recorded in 2016. Global brand spending is forecast to increase to USD 815-832 billion in 2021. Global generic spending is expected to increase to USD 495-505 billion by 2021.

The United States share of global spending will increase from USD 461.7 billion in 2016 to USD 645-675 billion in 2021, while the European share of spending will grow from USD 151.8 billion to USD 170-200 billion. Meanwhile, pharmerging countries will spend nearly 315-345 USD billion in 2021 from 242.9 in 2016.

Major Pharmacology Associations around the Globe

• American Academy of Veterinary Pharmacology and Therapeutics
• American Board of Clinical Pharmacology
• Argentine Society for Experimental Pharmacology
• Association of Pharmacologists of Ukraine
• Australian Physiological and Pharmacological Society
• British Association for Psychopharmacology
• Colombian Association of Pharmacology

Glance at Market of Pharmacology:

These data describe the outcome of the patient as defined in U.S.reporting regulations. Serious means that one or more of the following outcomes were documented in the report: death, hospitalization, life threatening. There is a need to impede serious adverse effects caused by the drugs by enhancing drug targeting through research in pharmacology.